alexa Gene-eluting Stents For The Prevention Of Restenosis
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Ilia Fishbein
ScientificTracks Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.008
Abstract
Delivery of gene vectors from a stent surface for gene therapy of restenosis poses major challenges due to issues related to stent functionality, biocompatibility of coatings, vector retention, and maintenance of vector viability. Our group has introduced a family of polyallylamine bisphosphonate (PAB) compounds that can effectively activate stents for covalently attaching vector- binding molecules using affinity tethering, or directly immobilizing vectors through hydrolysable cross-linkers. A water-soluble PABs (with or without latent thiol groups) were synthesized combining vinylidene-bisphosphonic acid and polyallylamine ? succinimidyl 3-propyldithiopropionate. Following formation of a PAB monolayer on the surface of model stainless steel meshes or stents, the surface was activated by attaching a recombinant domain (D1) containing the adenovirus binding region of the Coxsackie-Adenovirus receptor and subsequent affinity binding of Ad vector. Alternatively, after deprotection of thiol groups, Ad or AAV vectors were directly bound to the steel surface of the stent using bifunctional thiol-, amine-reactive hydrolysable cross-linkers. Both methods of vector immobilization allowed for sustained release of immobilized vectors, and site-specific localized expression both in vitro and in vivo , as demonstrated with Ad-GFP (fluorescence microscopy and immunohistochemistry) and Ad-Luc (bioluminescence imaging). Attachment of Ad vectors encoding inducible nitric oxide synthase (Ad-iNOS) to the surface of stents resulted in mitigation of post-angioplasty restenosis in the rat carotid model. The therapeutic effects of Ad-iNOS gene therapy delivered from the stent platform can be further modulated by pharmacological intervention with arginine and tetrahydrobiopterin to optimize the ratio between nitric oxide and reactive oxygen species produced by the stented arteries.
Biography
Ilia Fishbein received a M.D. degree from the University of Saratov (Russia) in 1987. He completed his Ph.D. studies on polymeric delivery systems for the prevention of restenosis at the Hebrew University of Jerusalem (Israel) in 2000. His post-doctoral research at the Children?s Hospital of Philadelphia (USA) has been concerned with vascular gene therapy and substrate-mediated delivery systems of viral vectors to diseased vasculature. He is an Assistant Professor at the University of Pennsylvania. His current work is related to gene-eluting stents and pharmacological modulation of vascular gene therapy for the prevention of restenosis.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]ine.com

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version